Zanetta S. Lamar

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

Youn H. Kim, M. Bagot, Lauren Pinter‐Brown et al. · The Lancet Oncology · 2018 · 621 citations · Full text

Cutaneous T-cell Lymphoma, Lymphoid Neoplasia, Medicine +6

Left Ventricular Mass Change After Anthracycline Chemotherapy

Jennifer H. Jordan, Sharon M. Castellino, Giselle C. Meléndez et al. · Circulation Heart Failure · 2018 · 132 citations · Full text

A Phase II Clinical Trial of CPI-613 in Patients with Relapsed or Refractory Small Cell Lung Carcinoma

Thomas Lycan, Timothy S. Pardee, W. Jeffrey Petty et al. · PLoS ONE · 2016 · 56 citations · Full text

Frequency of Left Ventricular End-Diastolic Volume–Mediated Declines in Ejection Fraction in Patients Receiving Potentially Cardiotoxic Cancer Treatment

Giselle C. Meléndez, Bunyapon Sukpraphrute, Ralph B. D’Agostino et al. · The American Journal of Cardiology · 2017 · 41 citations · Full text

Heart Failure, Cardiovascular Disease, Cardiac Mechanic +10

Simultaneous Left Ventricular Volume and Strain Changes During Chemotherapy Associate With 2‐Year Postchemotherapy Measures of Left Ventricular Ejection Fraction

Cynthia K. Suerken, Ralph B. D’Agostino, Jennifer H. Jordan et al. · Journal of the American Heart Association · 2020 · 27 citations · Full text